Nicholas A Saunders Selected Research

Nicholas A Saunders Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 07/2002
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 06/2004
6	Squamous Cell Carcinoma of Head and Neck 01/2018 - 02/2009
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 10/2019
3	Neoplasm Metastasis (Metastasis) 06/2020 - 01/2014
3	Adenocarcinoma 06/2016 - 07/2013
2	Carcinogenesis 01/2022 - 05/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 11/2005
2	Osteosarcoma (Osteogenic Sarcoma) 06/2020 - 09/2010
2	Actinic Keratosis 01/2019 - 01/2015
2	Breast Neoplasms (Breast Cancer) 12/2015 - 12/2011
2	Wounds and Injuries (Trauma) 08/2010 - 03/2008
2	Mumps 12/2002 - 03/2002
2	Obstructive Sleep Apnea 03/2002 - 01/2002
1	Melanoma (Melanoma, Malignant) 01/2023
1	Disease Progression 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Contact Dermatitis (Eczema, Contact) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2010
1	Cicatrix (Scar) 08/2010
1	Virus Diseases (Viral Diseases) 08/2007
1	Keratosis 05/2007
1	Infections 11/2005
1	Measles 12/2002
1	Rubella (German Measles) 12/2002
1	Apnea 03/2002
1	Vaccine-Preventable Diseases 03/2002

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2004
5	AntibodiesIBA 01/2020 - 03/2002
3	Epidermal Growth Factor (EGF)IBA 01/2019 - 07/2002
3	Biomarkers (Surrogate Marker)IBA 06/2016 - 07/2013
3	DNA (Deoxyribonucleic Acid)IBA 12/2015 - 06/2004
3	ErbB Receptors (EGF Receptor)IBA 01/2015 - 07/2002
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2013
2	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 05/2020
2	AnthracyclinesIBA 01/2018 - 01/2015
2	Glycoproteins (Glycoprotein)IBA 06/2016 - 11/2015
2	Cisplatin (Platino)FDA LinkGeneric 08/2010 - 11/2005
2	alpha-2-HS-GlycoproteinIBA 08/2010 - 03/2008
2	Immunoglobulin G (IgG)IBA 12/2002 - 03/2002
1	Immune Checkpoint InhibitorsIBA 01/2023
1	ibrutinibIBA 01/2023
1	Auranofin (Ridaura)FDA Link 06/2020
1	Thioredoxin Reductase 2IBA 06/2020
1	SpectrinIBA 05/2020
1	involucrinIBA 05/2020
1	adducinIBA 05/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Prochlorperazine (Compazine)FDA LinkGeneric 01/2020
1	AntiemeticsIBA 01/2020
1	fludarabineIBA 10/2019
1	LigandsIBA 01/2019
1	selinexorIBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Exportin 1 ProteinIBA 01/2018
1	AntigensIBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2016
1	LectinsIBA 06/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2015
1	sphingosine kinaseIBA 01/2015
1	3-deazaneplanocinIBA 01/2013
1	Tartrate-Resistant Acid PhosphataseIBA 09/2010
1	Interleukin-6 (Interleukin 6)IBA 08/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 02/2009
1	Blood Proteins (Serum Proteins)IBA 03/2008
1	Messenger RNA (mRNA)IBA 08/2007
1	Glutathione PeroxidaseIBA 05/2007
1	PeroxidesIBA 05/2007
1	TransglutaminasesIBA 05/2005
1	Histone Deacetylase InhibitorsIBA 03/2005
1	NucleoproteinsIBA 12/2002
1	laminin 10IBA 10/2002
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 07/2002
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2002
1	Complementary DNA (cDNA)IBA 07/2002
1	Indicators and Reagents (Reagents)IBA 03/2002
1	VaccinesIBA 03/2002

Therapy/Procedure

7	Therapeutics 01/2020 - 03/2005
3	Drug Therapy (Chemotherapy) 10/2019 - 11/2005
2	Continuous Positive Airway Pressure 03/2002 - 01/2002
1	Heterologous Transplantation (Xenotransplantation) 11/2010